Sign In
test

Irshad Karim

Lion Point Capital, Lp

Assets Managed
$16.732M
Holdings
35
Last Quarter
2026 - Q1
Filed Date
15d ago
Growth Rate
-13.41%(2Q avg: -1.81%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Lion Point Capital, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 35 positions.

Assets under management

The assets under management (AUM) of Lion Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 16.732M in assets, with a quarterly growth rate of -13.41% and a 2-quarter average growth rate of -1.81%. The portfolio is managed by Irshad Karim, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
PRAX
Praxis Precision Medicines I
Recent Activity
8.57%
$1.434M
4,450 shares@ $322.2 avg price
MLTX
Moonlake Immunotherapeutics
Recent Activity
7.52%
$1.258M
67,500 shares@ $18.64 avg price
RPRX
Royalty Pharma Plc- Cl A
Recent Activity
6.14%
$1.027M
21,400 shares@ $47.97 avg price
MIST
Milestone Pharmaceuticals In
Recent Activity
Increased 8.61%
5.84%
$975,800
820,000 shares@ $1.19 avg price
GERN
Geron Corp
Recent Activity
5.15%
$861,220
578,000 shares@ $1.49 avg price
SNDX
Syndax Pharmaceuticals Inc
Recent Activity
5.03%
$840,960
36,000 shares@ $23.36 avg price
ARDX
Ardelyx Inc
Recent Activity
4.61%
$770,614
128,650 shares@ $6.0 avg price
FENC
Fennec Pharmaceuticals Inc
Recent Activity
4.14%
$691,469
112,434 shares@ $6.15 avg price
BNTC
Benitec Biopharma Inc
Recent Activity
3.95%
$660,300
62,000 shares@ $10.65 avg price
SRPT
Sarepta Therapeutics Inc
Recent Activity
3.71%
$620,160
28,500 shares@ $21.76 avg price

1-10 of 35